CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax

Katharina Mattes, Mylène Gerritsen, Hendrik Folkerts, Marjan Geugien, Fiona A van den Heuvel, Arthur Flohr Svendsen, Guoqiang Yi, Joost H A Martens, Edo Vellenga*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
55 Downloads (Pure)
Original languageEnglish
Pages (from-to)e399-e403
Number of pages5
JournalHaematologica
Volume105
Issue number8
Early online date14-Nov-2019
DOIs
Publication statusPublished - 1-Aug-2020

Keywords

  • RESISTANCE

Cite this